QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)
QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)
QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)
QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)

Graybug Vision Stock Price, News & Analysis (NASDAQ:GRAY)

$3.38
-0.01 (-0.29%)
(As of 12/7/2023 ET)
Compare
Today's Range
$3.28
▼
$3.40
50-Day Range
$1.78
▼
$4.15
52-Week Range
$5.00
▼
$22.12
Volume
5,102 shs
Average Volume
2,165 shs
Market Capitalization
$5.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media

GRAY stock logo

About Graybug Vision Stock (NASDAQ:GRAY)

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

GRAY Stock Price History

GRAY Stock News Headlines

November 14, 2023 | usatoday.com
Best vision insurance companies of November 2023
August 3, 2023 | markets.businessinsider.com
Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer
December 8, 2023 | Edge On The Street (Ad)
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
June 10, 2023 | appleinsider.com
Apple Vision Pro $3,499 mixed-reality headset launches at WWDC after years of rumors
March 28, 2023 | marketwatch.com
Ocular Drug Delivery Technology Market Outlook By 2031
March 22, 2023 | finanznachrichten.de
Graybug Vision, Inc. Announces Name and Trading Symbol Change
March 21, 2023 | finanznachrichten.de
Graybug Vision, Inc.: Graybug Announces Name and Trading Symbol Change
March 21, 2023 | benzinga.com
Graybug Vision Stock (NASDAQ:GRAY), Dividends
December 8, 2023 | Edge On The Street (Ad)
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
March 20, 2023 | finance.yahoo.com
CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
March 20, 2023 | finance.yahoo.com
Individual investors are Graybug Vision, Inc.'s (NASDAQ:GRAY) biggest owners and were hit after market cap dropped US$31m
March 20, 2023 | finance.yahoo.com
Graybug Announces Name and Trading Symbol Change
February 27, 2023 | marketwatch.com
Ocular Drug Delivery Technology Market is Booming Worldwide with Top Countries Data
February 14, 2023 | businesswire.com
GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY
February 9, 2023 | finanznachrichten.de
DelveInsight Business Research, LLP: The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
February 9, 2023 | yahoo.com
The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
January 25, 2023 | seekingalpha.com
GRAY Graybug Vision, Inc.
December 6, 2022 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL
December 5, 2022 | wsj.com
INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of Graybug Vision, Inc. - GRAY
November 24, 2022 | benzinga.com
GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY
November 22, 2022 | marketwatch.com
GRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to Shareholders
November 22, 2022 | marketwatch.com
Graybug Vision Shares Fall Premarket on CalciMedica Tie-Up >GRAY
November 22, 2022 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedica
November 22, 2022 | finance.yahoo.com
Graybug Vision Agrees To Merge With Inflammatory Disease-Focused Biopharma
November 22, 2022 | finanznachrichten.de
Graybug Vision, Inc.; CalciMedica Inc.: Graybug and CalciMedica Enter into Definitive Merger Agreement
November 10, 2022 | finance.yahoo.com
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
September 16, 2022 | finance.yahoo.com
Diality Names Pamela Wapnick as Chief Financial Officer
See More Headlines
Receive GRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
12/08/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GRAY
CUSIP
N/A
CIK
1534133
Web
www.graybug.com
Phone
N/A
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($24.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-35,600,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-77.61%
Return on Assets
-71.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.73
Quick Ratio
10.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
2.03

Miscellaneous

Outstanding Shares
1,571,000
Free Float
20,250,000
Market Cap
$5.32 million
Optionable
Not Optionable
Beta
1.20
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Frederic Guerard Pharm.D. (Age 49)
    Pres, CEO, Sec. & Director
    Comp: $931.02k
  • Mr. Robert S. BreuilMr. Robert S. Breuil (Age 60)
    CFO & Treasurer
    Comp: $577.47k
  • Dr. Gerald D. Cagle Ph.D. (Age 78)
    Sr. Advisor & Head of Bus. Devel.
    Comp: $44.67k
  • Dr. Parisa Zamiri M.D. (Age 57)
    Ph.D., Chief Medical Officer
    Comp: $662.11k
  • Dr. Peter A. Campochiaro M.D.
    Co-Founder
  • Dr. Peter J. McDonnell M.D. (Age 63)
    Co-Founder
  • Ms. Bettina Maunz
    Chief People Officer & Head of Communications
  • Mr. Ming Yang
    Sr. VP of R&D
  • Dr. Ward M. Peterson Ph.D.
    Sr. VP of Preclinical Devel.
  • Mr. Ali Kakavand Ph.D.
    VP & Head of Program Management

Key Competitors

View All Competitors














GRAY Stock Analysis - Frequently Asked Questions

How have GRAY shares performed in 2023?

Graybug Vision's stock was trading at $7.00 on January 1st, 2023. Since then, GRAY stock has decreased by 51.6% and is now trading at $3.3850.
View the best growth stocks for 2023 here.

How were Graybug Vision's earnings last quarter?

Graybug Vision, Inc. (NASDAQ:GRAY) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($5.32) earnings per share for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14.

When did Graybug Vision's stock split?

Shares of Graybug Vision reverse split before market open on Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Graybug Vision IPO?

(GRAY) raised $75 million in an initial public offering on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler served as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers.

Who are Graybug Vision's major shareholders?

Graybug Vision's stock is owned by many different retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.

How do I buy shares of Graybug Vision?

Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:GRAY) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -